The estimated Net Worth of David G Ichikawa is at least $3.36 Tisíc dollars as of 7 July 2011. David Ichikawa owns over 4,000 units of Sangamo Therapeutics Inc stock worth over $3,360 and over the last 19 years David sold SGMO stock worth over $0.
David has made over 7 trades of the Sangamo Therapeutics Inc stock since 2008, according to the Form 4 filled with the SEC. Most recently David exercised 4,000 units of SGMO stock worth $20,760 on 7 July 2011.
The largest trade David's ever made was exercising 15,000 units of Sangamo Therapeutics Inc stock on 20 May 2008 worth over $77,850. On average, David trades about 4,643 units every 91 days since 2005. As of 7 July 2011 David still owns at least 4,000 units of Sangamo Therapeutics Inc stock.
You can see the complete history of David Ichikawa stock trades at the bottom of the page.
Over the last 24 years, insiders at Sangamo Therapeutics Inc have traded over $87,969,621 worth of Sangamo Therapeutics Inc stock and bought 3,434,008 units worth $48,483,268 . The most active insiders traders include Capital Management, L.P.Ra ..., Le Roy C Kopp a Inc.Biogen Ma Inc. Biogen. On average, Sangamo Therapeutics Inc executives and independent directors trade stock every 21 days with the average trade being worth of $40,671. The most recent stock trade was executed by Inc.Biogen Ma Inc. Biogen on 26 September 2023, trading 6,000,000 units of SGMO stock currently worth $3,000,000.
for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.
Sangamo Therapeutics Inc executives and other stock owners filed with the SEC include: